Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA…
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA…